Advanced Filters
noise
Found 84 clinical trials
A Axel Brandes, Medical degree and Professor

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion

Background Atrial fibrillation (AF) is the most common heart rhythm disorder worldwide. Globally, there are 37.5 million people with AF. AF increases the risk of death, heart failure, and stroke, which severely affect patients and also lead to high healthcare costs. Around 25% of all strokes are caused by AF, …

18 years of age All Phase N/A
N Nir Uriel, MD

Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device

Heart failure is a world epidemic. LVADs are increasingly used as they have demonstrated improved survival rates compared to optimal medical management. Improving outcomes have been seen with the newer LVAD technology, the HeartMate 3 (Abbott, Chicago, IL), however, hemocompatibility related adverse events, including thrombosis and bleeding, are still a …

18 years of age All Phase 4
V Veronica Bates, BSc, CCRP

A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg

The goal of this clinical trial, called a pilot study or a feasibility study, is to test the study plan and to find out whether enough participants will join a larger study and accept the study procedures. This type of study includes a small number of participants so it is …

18 years of age All Phase 2/3
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Platelet Volunteers, Longitudinal and Multi-omic Study

Background Platelets are a type of blood cell that play a critical role in bleeding, forming blood clots, and healing. Researchers want to know more about platelets work in healthy people. They want to look at how platelets clump together, how blood clots, and how genes and proteins work. They …

18 - 100 years of age All Phase N/A
J Joseph Shatzel, M.D.

Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT

This phase II trial studies how well gruticibart works in reducing the incidence of catheter-related thrombosis (CRT) blood clots in patients with a central venous catheter (CVC) inserted. Many patients develop blood clots from their catheters and can have pain, swelling, and other symptoms. They also often require blood thinners, …

18 years of age All Phase 2
J Jason H Karnes, PharmD, PhD

Pharmacogenomics of Warfarin in Hispanics and Latinos

Warfarin is a commonly used blood thinner to treat and prevent blood clots. It is important to take the right dose of warfarin because too much can increase the risk of bleeding and too little can increase the risk of blood clots. This is why patients are closely monitored especially …

18 years of age All Phase N/A
J Jinhao Lyu, MD

Thrombus Imaging and Treatment Analytics in Neurology

In the present study, the investigators use high-resolution MR vessel wall imaging, and select patients with cerebral and cervical artery occlusion to investigate the relationship between the imaging appearance of thrombus and the various outcome of recanalization treatment.

18 years of age All Phase N/A
G Giorgio Prouse, MD

A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy Catheters

A PMCF study to confirm the performance and safety of the LeMaitre® TufTex Over-the-Wire Embolectomy Catheter

18 years of age All Phase N/A
H Haonan Yu, MD

Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related Disease

In the field of diagnosing Thrombi diseases, it is now a well established practice to inject positron-emitting tracers into the human body. These tracers bind to specific target proteins, allowing their distribution to be visualized via PET imaging. Currently, several research groups worldwide are engaged in developing and clinically validating …

18 - 90 years of age All Phase N/A
A Alex B Chebl, MD

Michigan Initial Experience Using Tigertriever for Thrombectomy

The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in …

18 years of age All Phase N/A

Simplify language using AI